Patents by Inventor WENDY CAROL PIACENZA

WENDY CAROL PIACENZA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210106658
    Abstract: Compositions are provided comprising recombinant variants of the human clotting Factor Xa. Such compositions include a wide variety of isoforms and post-translational modifications of FXa and are useful for treating subjects in need of hemostasis.
    Type: Application
    Filed: May 25, 2020
    Publication date: April 15, 2021
    Inventors: KEITH A. JOHNSON, JASON C. ROUSE, PENELOPE JANE SHARPE, MICHAEL SHAMASHKIN, WENDY CAROL PIACENZA, MARY BETH SWITZER, STACEY B. WESTON, Michael Anthony JANKOWSKI
  • Patent number: 10660946
    Abstract: Compositions are provided comprising recombinant variants of the human clotting Factor Xa. Such compositions include a wide variety of isoforms and post-translational modifications of FXa and are useful for treating subjects in need of hemostasis.
    Type: Grant
    Filed: August 4, 2017
    Date of Patent: May 26, 2020
    Assignee: Pfizer Inc.
    Inventors: Keith A. Johnson, Jason C. Rouse, Penelope Jane Sharpe, Michael Shamashkin, Wendy Carol Piacenza, Mary Beth Switzer, Stacey B. Weston, Michael Anthony Jankowski
  • Publication number: 20170333535
    Abstract: Compositions are provided comprising recombinant variants of the human clotting Factor Xa. Such compositions include a wide variety of isoforms and post-translational modifications of FXa and are useful for treating subjects in need of hemostasis.
    Type: Application
    Filed: August 4, 2017
    Publication date: November 23, 2017
    Inventors: KEITH A. JOHNSON, JASON C. ROUSE, PENELOPE JANE SHARPE, MICHAEL SHAMASHKIN, WENDY CAROL PIACENZA, MARY BETH SWITZER, STACEY B. WESTON, Michael Anthony JANKOWSKI
  • Publication number: 20150182604
    Abstract: Compositions are provided comprising recombinant variants of the human clotting Factor Xa. Such compositions include a wide variety of isoforms and post-translational modifications of FXa and are useful for treating subjects in need of hemostasis.
    Type: Application
    Filed: September 24, 2014
    Publication date: July 2, 2015
    Inventors: KEITH A. JOHNSON, JASON C. ROUSE, PENELOPE JANE SHARPE, MICHAEL SHAMASHKIN, WENDY CAROL PIACENZA, MARY BETH SWITZER, STACEY B. WESTON, Michael Anthony JANKOWSKI